Capsules: Health Care News and Ideas for Medical Conference Organizers

FDA NOTE The Coalition for Healthcare Communication (CHC) has released a position paper proposing new Food and Drug Administration guidelines for company dissemination of off-label (uses unapproved by the FDA) drug information. Recently, the U.S. District Court for the District of Columbia found that existing FDA guidelines and related provisions of the FDA Modernization Act are unconstitutional. The FDA has appealed the court's decision.

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.